| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2023 | AMGEN, INC. |
3rd Quarter (July 1 - Sep 30) AMENDED |
$2,980,000 | |
| 2023 | AMGEN, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$3,550,000 | |
| 2023 | AMGEN, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$2,240,000 | |
| 2023 | AMGEN, INC. |
2nd Quarter (Apr 1 - June 30) AMENDED |
$1,950,000 | |
| 2023 | AMGEN, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$1,950,000 | |
| 2023 | AMGEN, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$2,800,000 |
| Firm | Filings | Expenses |
|---|---|---|
| AMGEN, INC. | 84 | $206,735,000 |
| Issue | Activities |
|---|---|
| Health Issues | 84 |
| Medicare/Medicaid | 84 |
| Taxation/Internal Revenue Code | 81 |
| Copyright/Patent/Trademark | 79 |
| Trade (domestic/foreign) | 9 |
| Tariff (miscellaneous tariff bills) | 6 |